Characterization of the cellular lipid composition during SARS-CoV-2 infection-Reference-Cited by-同舟云学术

Characterization of the cellular lipid composition during SARS-CoV-2 infection

Published:2023-07-13 Issue:22 Volume:415 Page:5269-5279
ISSN:1618-2642
Container-title:Analytical and Bioanalytical Chemistry
language:en
Short-container-title:Anal Bioanal Chem

Author:

Abdel-Megied Ahmed M.^ORCID,Monreal Isaac A.^ORCID,Zhao Limian,Apffel Alex,Aguilar Hector C.^ORCID,Jones Jace W.^ORCID

Funder

University of Maryland School of Pharmacy Faculty Start-up funds

Agilent Research Gift

University of Maryland, Baltimore, Institute for Clinical & Translational Research (ICTR) and the National Center for Advancing Translational Sciences (NCATS) Clinical Translational Science Award

National Institutes of Health

George Mason Univ. Fast Grant

University of Maryland School of Pharmacy Mass Spectrometry Center

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry,Analytical Chemistry

Link

https://link.springer.com/content/pdf/10.1007/s00216-023-04825-1.pdf

Reference47 articles.

1. Åsjö B, Kruse H. Zoonoses in the emergence of human viral diseases. Perspect Med Virol. 2006;16:15–41.

2. Johns Hopkins University and Medicine CRC. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) 2020 [Available from: https://coronavirus.jhu.edu/map.html. Accessed 22 March 2023.

3. Sweileh WM. Global research trends of World Health Organization’s top eight emerging pathogens. Global Health. 2017;13(1):9.

4. Vigant F, Santos NC, Lee B. Broad-spectrum antivirals against viral fusion. Nat Rev Microbiol. 2015;13(7):426–37.

5. Chan RB, Tanner L, Wenk MR. Implications for lipids during replication of enveloped viruses. Chem Phys Lipid. 2010;163(6):449–59.